ARMEL SIMO: Open Payments
NPI 1376708321 · CATONSVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,239 in 22 payments from 9 companies in 2025. Trend: 2023 $1,089 · 2024 $945 · 2025 $1,239
Food & beverage: $1,239
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $656 |
| Gilead Sciences, Inc. | 2 | $131 |
| Novo Nordisk Inc | 2 | $130 |
| ViiV Healthcare Company | 1 | $109 |
| Indivior Inc. | 3 | $91 |
| Exact Sciences Corporation | 3 | $56 |
| Amgen Inc. | 1 | $26 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| Lilly USA, LLC | 1 | $20 |
Products named: AIRSUPRA, Ozempic, CABENUVA, Yeztugo, SUBLOCADE, Cologuard Collection Kit, BREZTRI, FARXIGA.
Industry payments across MD — which companies pay providers there.
